ARTICLE
25 August 2026

China’s Biotech Rise, Healthcare Today

Partners Emmanuelle Trombe and Anthony Paronneau examine China's emergence as a global biotechnology innovation hub, exploring cross-border collaboration models and critical considerations for life sciences companies engaging in China-related transactions. The analysis covers intellectual property protection, regulatory compliance frameworks, data management protocols, and foreign investment screening requirements.
Worldwide Food, Drugs, Healthcare, Life Sciences
Emmanuelle Trombe’s articles from McDermott Will & Schulte are most popular:
  • within Food, Drugs, Healthcare and Life Sciences topic(s)
  • with readers working within the Business & Consumer Services industries
McDermott Will & Schulte are most popular:
  • within Privacy, International Law and Consumer Protection topic(s)

Partners Emmanuelle Trombe and Anthony Paronneau co-authored a Healthcare Today article examining China’s rise as a global biotechnology innovation hub and the opportunities it presents for life sciences companies.

They explore cross-border collaboration models and key considerations for China-related transactions, including intellectual property, regulatory compliance, data management, and foreign investment screening.

Read the full Healthcare Today article >>

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More